肝移植后减毒活疫苗失败:一项20年队列研究
本研究在庆应义塾大学医院于2002年至2023年8月前瞻性纳入67例肝移植受者,评估接种减毒活疫苗后原发性和继发性疫苗失败的相关因素。结果显示疫苗株而非使用两种及以上免疫抑制剂与较低疫苗失败风险相关,不同疫苗株的失败率存在差异。结论认为疫苗株是影响肝移植后减毒活疫苗接种失败的最关键因素。
要点
- 在67例肝移植受者中,54、55、47和55例分别接种至少一剂麻疹、风疹、水痘和腮腺炎减毒活疫苗。
- 麻疹AIK-C株的原发性和继发性失败率均显著低于CAM-70株(1/38 vs. 4/16,比值比0.08,95%CI 0.01-0.80,p=0.02;风险比0.54,95%CI 0.34-0.85,p=0.01)。
- 风疹TO-336株未观察到原发性失败,而松浦株10例中4例未血清阳转;腮腺炎Hoshino株原发失败率低于Torii株(15/52 vs. 3/3,p=0.03)。
核心结论
- 根据一项20年长期研究,疫苗株是影响移植后减毒活疫苗接种原发性和继发性失败的最关键因素。
研究设计与样本
- 前瞻性研究,2002年至2023年8月在庆应义塾大学医院开展,纳入67例符合减毒活疫苗接种标准(包括体液和细胞免疫标准)的肝移植受者。
主要发现
- 在67例肝移植受者中,54、55、47和55例分别接种至少一剂麻疹、风疹、水痘和腮腺炎减毒活疫苗。
- 疫苗株差异而非使用两种及以上免疫抑制剂与较低的疫苗失败风险相关。
- 麻疹AIK-C株的原发性和继发性失败率均显著低于CAM-70株(1/38 vs. 4/16,比值比0.08,95%CI 0.01-0.80,p=0.02;风险比0.54,95%CI 0.34-0.85,p=0.01)。
- 风疹TO-336株未观察到原发性失败,而松浦株10例肝移植受者中4例未血清阳转。
- 腮腺炎Hoshino株的原发失败率低于Torii株(15/52 vs. 3/3,p=0.03)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A recent conditional recommendation suggests considering live-attenuated vaccines for solid organ transplant recipients, yet the conditions of their safe and effective administration remain unclear. METHODS: This prospective study was conducted at Keio University Hospital from 2002 to August 2023. We gave a live-attenuated vaccine to liver transplant (LT) recipients fulfilling criteria for live-attenuated vaccines, including criteria for humoral and cell-mediated immunity. Patient background information, immunization date, vaccine strain, immunosuppressive agents at the time of vaccination, and antibody titers were collected. Factors related to primary and secondary vaccine failure were evaluated to enhance the effectiveness of the live-attenuated vaccine program after LT. RESULTS: Among 67 LT recipients, 54, 55, 47, and 55 received at least one dose of live-attenuated vaccine for measles, rubella, varicella, and mumps, respectively. The difference in vaccine strains, but not the use of two or more immunosuppressive agents, was associated with a lower risk of vaccine failures. Measles vaccine with the AIK-C strain exhibited significantly lower primary and secondary failure rates than the CAM-70 strain (1/38 vs. 4/16, odds ratio: 0.08, 95 % confidence interval [CI]: 0.01-0.80, p = 0.02, and hazard ratio: 0.54, 95 % CI: 0.34-0.85, p = 0.01, respectively). No primary failures were observed with the TO-336 strain of rubella, whereas 4 of 10 LT recipients with the Matsuura strain of rubella did not seroconvert. For mumps, the Hoshino strain showed lower primary failure rates than the Torii strain (15/52 vs. 3/3, p = 0.03). CONCLUSION: According to a 20-year long-term study, vaccine strains are the most critical factor influencing primary and secondary vaccine failure in post-transplant live-attenuated vaccination.
引用
- Furuichi M, Ohnishi T, Yaginuma M, et al. Live-attenuated vaccine failure after liver transplantation: A 20-year cohort study. Vaccine. 2024. PMID: 39547018. doi:10.1016/j.vaccine.2024.126527
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。